Six-Month Doxycycline Is Safe and Effective As Upfront Monotherapy for Stage-I Malt Lymphoma of the Ocular Adnexae: Primary Endpoint Results of the IELSG39 Trial
Abstract
Publication Date:
2022
Short description:
Six-Month Doxycycline Is Safe and Effective As Upfront Monotherapy for Stage-I Malt Lymphoma of the Ocular Adnexae: Primary Endpoint Results of the IELSG39 Trial / Ferreri, Ajm; Sassone, Mc; Cangi, Mg; Magliacane, G; Zanussi, S; Flospergher, E; Marino, F; Bongiovanni, L; Ladetto, M; Cavallo, F; Aversa, F; Anastasia, A; Mannina, D; Pascarella, A; Vallisa, D; Pulsoni, A; Bonomini, L; Bertoni, F; Dolcetti, R; Zucca, E; Ponzoni, M. - In: BLOOD. - ISSN 0006-4971. - 140:(2022), pp. 6482-6484. [10.1182/blood-2022-168712]
Iris type:
4.2 Abstract in Atti di convegno
List of contributors:
Ferreri, Ajm; Sassone, Mc; Cangi, Mg; Magliacane, G; Zanussi, S; Flospergher, E; Marino, F; Bongiovanni, L; Ladetto, M; Cavallo, F; Aversa, F; Anastasia, A; Mannina, D; Pascarella, A; Vallisa, D; Pulsoni, A; Bonomini, L; Bertoni, F; Dolcetti, R; Zucca, E; Ponzoni, M
Book title:
140 (Supplement 1): 6482–6484.
Published in: